Thrombin topical (Human, Ethicon/OMRIX Biopharmaceuticals)

N/A

Report date: 2022/01/22 15:19:20

Base Information

Drug NameThrombin topical (Human, Ethicon/OMRIX Biopharmaceuticals)
Drug Alias Name人凝血酶Human plasma-derived thrombinEvithrom
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factorBiologics > Blood components
Mechanisms of ActionFibrinogen stimulants
TargetsFibrinogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2007/08/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEthiconOmrix Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeB02BC06B02BD30
Related LinksN/A